Date: 3.2.2014
Technology request: Treatment of muscular dystrophies and other disorders
Reference: TONL20131210003
Summary: A Dutch medical university has developed new method that uses exon skipping in ALK4 and ALK5 for treatment of muscular dystrophies and other disorders. They are interested in collaborations with pharmaceutical and biotech companies for researching and developing treatments for muscular dystrophy.
For more information click here.
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2025 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Africa Biotech - Biotechnology and African Agriculture news
Práce - Nabidky prace
CRISPR/Cas9 modifies Euglena to create potential biofuel source
First lung cancer vaccine given to patient in international trial